4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (25%) |
| §103 only | 1 (25%) |
| No statute on record | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MONTANARI, DAVID A | 1 | 65.1% | +49.6% |
| BRETZ, COREY LANE | 1 | 0.0% | +0.0% |
| REGLAS, GEORGIANA C | 1 | 38.8% | +30.2% |
| RYAN, DOUGLAS CHARLES | 1 | 40.0% | +48.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18348128 | MAD NUCLEASES | REGLAS, GEORGIANA C | 91d overdue |
| 18240550 | METHODS FOR INCREASED NUCLEIC ACID-GUIDED CELL EDITING | BRETZ, COREY LANE | 3d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18348128 | MAD NUCLEASES | REGLAS, GEORGIANA C | 91d overdue |
| 18166868 | CURE ALL FOR NUCLEIC ACID-GUIDED CELL EDITING IN E. COLI | RYAN, DOUGLAS CHARLES | 45d overdue |
| 18491049 | DUAL STRAND NUCLEIC ACID-GUIDED NICKASE EDITING | MONTANARI, DAVID A | 10d overdue |
| Art Unit | Apps |
|---|---|
| 1635 | 2 |
| 1632 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18491049 | DUAL STRAND NUCLEIC ACID-GUIDED NICKASE EDITING | MONTANARI, DAVID A | 1632 | Other | Non-Final OA | 10d overdue | Pending | Oct 20, 2023 |
| 18240550 | METHODS FOR INCREASED NUCLEIC ACID-GUIDED CELL EDITING | BRETZ, COREY LANE | 1635 | §103 | Non-Final OA | 3d overdue | Pending | Aug 31, 2023 |
| 18348128 | MAD NUCLEASES | REGLAS, GEORGIANA C | 1651 | §101 | Non-Final OA | 91d overdue | Pending | Jul 06, 2023 |
| 18166868 | CURE ALL FOR NUCLEIC ACID-GUIDED CELL EDITING IN E. COLI | RYAN, DOUGLAS CHARLES | 1635 | Other | Non-Final OA | 45d overdue | Pending | Feb 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial